ConductScience.org, home

Paper10073735

The therapeutic monitoring of antimicrobial agents.

Begg EJ and 2 others. Br J Clin Pharmacol, 1999. Cited by 87 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The therapeutic monitoring of antimicrobial agents. Papers, record 10073735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10073735

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The therapeutic monitoring of antimicrobial agents.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1999
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
3.13
iCite
Revised in PubMed
2019-05-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Begg EJE J
2Barclay MLM L
3Kirkpatrick CJC J

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
Antifungal AgentsMajor topic
Drug MonitoringMajor topic
Aminoglycosides
Flucytosine
Humans
Itraconazole
Teicoplanin
Vancomycin

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06590428Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant TuberculosisBackground

Source ClinicalTrials.gov

Download CSV of trials

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13027853Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.Rev Infect Dis1987https://conductscience.org/library/papers/3027853PubMed
33303926Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.Am J Med1987https://conductscience.org/library/papers/3303926PubMed
43672575Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization.Ther Drug Monit1987https://conductscience.org/library/papers/3672575PubMed
53691013Routine monitoring of serum vancomycin concentrations: waiting for proof of its value.Clin Pharm1987https://conductscience.org/library/papers/3691013PubMed
62349619Errors in assuming a one-compartment model for vancomycin.Ther Drug Monit1990https://conductscience.org/library/papers/2349619PubMed
72351627Nephrotoxicity of vancomycin, alone and with an aminoglycoside.J Antimicrob Chemother1990https://conductscience.org/library/papers/2351627PubMed
81694421Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".Antimicrob Agents Chemother1990https://conductscience.org/library/papers/1694421PubMed
92195890Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone.Am J Med1990https://conductscience.org/library/papers/2195890PubMed
102393277Application of a Bayesian method to monitor and adjust vancomycin dosage regimens.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2393277PubMed
112127325Does accepting pharmacokinetic recommendations impact hospitalization? A cost-benefit analysis.Ther Drug Monit1990https://conductscience.org/library/papers/2127325PubMed
121860329Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients.Crit Care Med1991https://conductscience.org/library/papers/1860329PubMed
131315160Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.Clin Infect Dis1992https://conductscience.org/library/papers/1315160PubMed
143503577Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.Am J Med1987https://conductscience.org/library/papers/3503577PubMed
153061999The in-vitro degradation at 37 degrees C of vancomycin in serum, CAPD fluid and phosphate-buffered saline.J Antimicrob Chemother1988https://conductscience.org/library/papers/3061999PubMed
163505841Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.Clin Pharm1987https://conductscience.org/library/papers/3505841PubMed
172728513Evaluation of a Bayesian method for predicting vancomycin dosing.DICP1989https://conductscience.org/library/papers/2728513PubMed
183252194Evaluation of a method for initiating vancomycin therapy: experience in 205 patients.Pharmacotherapy1988https://conductscience.org/library/papers/3252194PubMed
192741194Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.Ther Drug Monit1989https://conductscience.org/library/papers/2741194PubMed
202745867A prospective randomised trial comparing individualised pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patients.Intensive Care Med1989https://conductscience.org/library/papers/2745867PubMed
212775618Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2775618PubMed

See all 58 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
41973123Amikacin pharmacokinetics, target attainment, and predictors in critically ill children: a retrospective cohort.Eur J Pediatr2026https://conductscience.org/library/papers/41973123PubMed
41803667A Machine Learning-Based Model for Individualized Prediction of Vancomycin Concentration-Time Curves in ICU Patients.Pharmacol Res Perspect2026https://conductscience.org/library/papers/41803667PubMed
41427737Alkylation-based optimization of antifungal FPPS inhibitors yields a potent, broad-spectrum lipophilic zoledronate derivative.mBio2026https://conductscience.org/library/papers/41427737PubMed
40458932Therapeutic Drug Monitoring of Amikacin and Colistin in Patients with Multidrug-Resistant Gram-Negative Infections Using a Portable Plasmonic Biosensor.Anal Chem2025https://conductscience.org/library/papers/40458932PubMed
40163845Optimizing Initial Vancomycin Dosing in Hospitalized Patients Using Machine Learning Approach for Enhanced Therapeutic Outcomes: Algorithm Development and Validation Study.J Med Internet Res2025https://conductscience.org/library/papers/40163845PubMed
40162779Terminal complement complexes with or without C9 potentiate antimicrobial activity against Neisseria gonorrhoeae.mBio2025https://conductscience.org/library/papers/40162779PubMed
39628461Design and synthesis of betulinic acid-dithiocarbamate conjugates as potential antifungal agents against Candida albicans.RSC Adv2024https://conductscience.org/library/papers/39628461PubMed
38503008Determining steady-state trough range in vancomycin drug dosing using machine learning.J Crit Care2024https://conductscience.org/library/papers/38503008PubMed
37371637Physiological Basis for Using Vitamin D to Improve Health.Biomedicines2023https://conductscience.org/library/papers/37371637PubMed
36364147An Overview of Analytical Methodologies for Determination of Vancomycin in Human Plasma.Molecules2022https://conductscience.org/library/papers/36364147PubMed
35436887Would they accept it? An interview study to identify barriers and facilitators to user acceptance of a prescribing advice service.BMC Health Serv Res2022https://conductscience.org/library/papers/35436887PubMed
35311044Errors in Antimicrobial Prescription and Administration in Very Low Birth Weight Neonates at a Tertiary South African Hospital.Front Pediatr2022https://conductscience.org/library/papers/35311044PubMed
34002357Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review.Clin Pharmacokinet2021https://conductscience.org/library/papers/34002357PubMed
33868859A Comprehensive Overview of Antibiotic Selection and the Factors Affecting It.Cureus2021https://conductscience.org/library/papers/33868859PubMed
32468446Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.Clin Pharmacokinet2020https://conductscience.org/library/papers/32468446PubMed
32219207High-Precision Control of Plasma Drug Levels Using Feedback-Controlled Dosing.ACS Pharmacol Transl Sci2018https://conductscience.org/library/papers/32219207PubMed
31979198Treating Intracranial Abscesses in Rats with Stereotactic Injection of Biodegradable Vancomycin-Embedded Microparticles.Pharmaceutics2020https://conductscience.org/library/papers/31979198PubMed
31828686Diagnostic and medical needs for therapeutic drug monitoring of antibiotics.Eur J Clin Microbiol Infect Dis2020https://conductscience.org/library/papers/31828686PubMed
30988147Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30988147PubMed
30709019Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge.Medicines (Basel)2019https://conductscience.org/library/papers/30709019PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10073735

GET https://conductscience.org/api/papers/v1/10073735/references?page=2